Medtronic Recalls Evera, Viva, Brava, Claria, Amplia, Compia, and Visia Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy (CRT-Ds) Due to Risk of Shortened Battery Life - LEADconnection

Medtronic Recalls Evera, Viva, Brava, Claria, Amplia, Compia, and Visia Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy (CRT-Ds) Due to Risk of Shortened Battery Life

Posted on November 9th, 2022
Bookmark
Please login to bookmarkClose

February 2021

Medtronic is recalling the specified ICDs and CRT-Ds due to an unexpected and rapid decrease in battery life. Some devices may progress from “Recommended Replacement Time” to full battery depletion within as little as one day. More information about this recall and patient management guidance can be found on the FDA website.